Assignee profile:

Nycomed GmbH

City:

Constance

Country:

Germany

Published Applications:

52

Last publication date:

2013-02-26

Patent Grants:

52

Last grant date:

2013-02-26

Top Inventors for applications by Nycomed GmbH

These are the the leading inventors for applications assigned to Nycomed GmbH:

Recent patent applications by Nycomed GmbH

Nycomed GmbH based in Constance, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2013-02-26 βœ… Patent 8,383,611 granted on 2013-02-26
US10110632
-

Ciclesonide containing aqueous pharmaceutical composition

#2 | 2011-12-22 βœ… Patent 8,163,299 granted on 2012-04-24
US20110308975A1
Human necessities

Stabilized pharmaceutical product

#3 | 2011-10-20 βœ… Patent 8,324,391 granted on 2012-12-04
US20110257221A1
Human necessities

Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

#4 | 2011-10-20 βœ… Patent 8,318,944 granted on 2012-11-27
US20110257169A1
Human necessities

Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

#5 | 2011-08-02 βœ… Patent 7,988,999 granted on 2011-08-02
US10433304
-

Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient

#6 | 2011-03-17 βœ… Patent 8,288,445 granted on 2012-10-16
US20110064814A1
Human necessities

Stable pharmaceutical products

#7 | 2010-09-30 βœ… Patent 8,029,811 granted on 2011-10-04
US20100247585A1
Human necessities

Stabilized pharmaceutical product

#8 | 2010-09-14 βœ… Patent 7,794,752 granted on 2010-09-14
US9980492
-

Preparation and administration form comprising an acid-labile active compound

#9 | 2010-07-29 βœ… Patent 8,354,535 granted on 2013-01-15
US20100190818A1
Human necessities

Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives

#10 | 2010-07-15 βœ… Patent 8,278,300 granted on 2012-10-02
US20100179152A1
Human necessities

Use for PDE5 inhibitors

#11 | 2010-05-13 βœ… Patent 8,304,436 granted on 2012-11-06
US20100120757A1
Chemistry; metallurgy

Pyrazolone derivatives as PDE4 inhibitors

#12 | 2010-02-11 βœ… Patent 8,329,906 granted on 2012-12-11
US20100035913A1
Chemistry; metallurgy

Guanidinyl-substituted hydroxy-6-phenylphenanthridines

#13 | 2009-12-08 βœ… Patent 7,629,361 granted on 2009-12-08
US10489659
-

Salt of (S)-pantoprazole and its hydrates

#14 | 2009-09-24 βœ… Patent 8,324,404 granted on 2012-12-04
US20090239895A1
Chemistry; metallurgy

3-thia-10-aza-phenanthrene derivatives

#15 | 2009-07-02 βœ… Patent 8,202,880 granted on 2012-06-19
US20090170892A1
Chemistry; metallurgy

3-hydroxy-6-phenylphenanthridines as PDE4 inhibitors

#16 | 2009-05-21 βœ… Patent 7,820,669 granted on 2010-10-26
US20090131448A1
Chemistry; metallurgy

2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors

#17 | 2009-05-21 βœ… Patent 7,790,710 granted on 2010-09-07
US20090131399A1
Chemistry; metallurgy

Imidazopyridine derivatives useful as iNOS inhibitors

#18 | 2009-01-29 βœ… Patent 8,198,295 granted on 2012-06-12
US20090030029A1
Chemistry; metallurgy

Benzonaphthyridines

#19 | 2009-01-01 βœ… Patent 7,851,472 granted on 2010-12-14
US20090005372A1
Chemistry; metallurgy

Triazolophthalazines

#20 | 2008-12-25 βœ… Patent 7,632,844 granted on 2009-12-15
US20080319067A1
Chemistry; metallurgy

2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors

#21 | 2008-12-18 βœ… Patent 8,106,047 granted on 2012-01-31
US20080312225A1
Chemistry; metallurgy

Triazolophthalazines

#22 | 2008-11-13 βœ… Patent 7,671,050 granted on 2010-03-02
US20080280907A1
Chemistry; metallurgy

Triazolophthalazines

#23 | 2008-10-16 βœ… Patent 8,242,146 granted on 2012-08-14
US20080255209A1
Human necessities

Combination of a NSAID and a PDE-4 inhibitor

#24 | 2008-09-04 βœ… Patent 8,017,633 granted on 2011-09-13
US20080214625A1
Human necessities

Roflumilast for the treatment of diabetes mellitus

#25 | 2008-08-14 βœ… Patent 7,718,668 granted on 2010-05-18
US20080194587A1
Human necessities

Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives

#26 | 2008-07-10 βœ… Patent 8,003,798 granted on 2011-08-23
US20080167301A1
Human necessities

Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

#27 | 2008-06-19 βœ… Patent 7,601,737 granted on 2009-10-13
US20080146610A1
Chemistry; metallurgy

Isotopically substituted proton pump inhibitors

#28 | 2008-04-15 βœ… Patent 7,357,943 granted on 2008-04-15
US10433305
-

Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient

#29 | 2008-04-01 βœ… Patent 7,351,723 granted on 2008-04-01
US10855703
-

Freeze-dried pantoprazole preparation and pantoprazole injection

#30 | 2008-03-20 βœ… Patent 7,785,630 granted on 2010-08-31
US20080069882A1
Human necessities

Preparation and administration form comprising an acid-labile active compound

#31 | 2007-12-27 βœ… Patent 8,236,750 granted on 2012-08-07
US20070299003A1
Human necessities

Composition comprising a pulmonary surfactant and a TNF-derived peptide

#32 | 2007-11-08 βœ… Patent 7,838,521 granted on 2010-11-23
US20070259868A1
Chemistry; metallurgy

3-oxa-10-aza-phenanthrenes

#33 | 2007-08-09 βœ… Patent 7,666,872 granted on 2010-02-23
US20070185114A1
Human necessities

Use for PDE5 inhibitors

#34 | 2007-08-02 βœ… Patent 7,494,990 granted on 2009-02-24
US20070179146A1
Chemistry; metallurgy

2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors

#35 | 2007-07-19 βœ… Patent 7,585,872 granted on 2009-09-08
US20070167482A1
Chemistry; metallurgy

Guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (PDE) 4 inhibitors

#36 | 2007-07-19 βœ… Patent 7,641,050 granted on 2010-01-05
US20070163918A1
Performing operations; transporting

Medicine pack

#37 | 2007-05-31 βœ… Patent 7,951,398 granted on 2011-05-31
US20070122474A1
Human necessities

Pharmaceutical preparation comprising an active dispersed on a matrix

#38 | 2007-02-01 βœ… Patent 8,371,292 granted on 2013-02-12
US20070025923A1
Human necessities

Use of ciclesonide for the treatment of respiratory diseases

#39 | 2006-12-28 βœ… Patent 7,279,488 granted on 2007-10-09
US20060293302A1
Chemistry; metallurgy

Imidazopyridine-derivatives as inducible no-synthase inhibitors

#40 | 2006-12-14 βœ… Patent 7,776,893 granted on 2010-08-17
US20060281745A1
Human necessities

Use of PDE4 inhibitors for the treatment of diabetes mellitus

#41 | 2006-11-23 βœ… Patent 7,402,321 granted on 2008-07-22
US20060263426A1
Human necessities

Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles

#42 | 2006-07-27 βœ… Patent 7,470,704 granted on 2008-12-30
US20060167034A1
Chemistry; metallurgy

Benzonaphthyridines

#43 | 2006-07-27 βœ… Patent 8,182,824 granted on 2012-05-22
US20060166953A1
Human necessities

Ciclesonide-containing sterile aqueous suspension

#44 | 2006-07-06 βœ… Patent 7,736,673 granted on 2010-06-15
US20060147537A1
Human necessities

Stabilized pharmaceutical product

#45 | 2006-06-15 βœ… Patent 7,790,198 granted on 2010-09-07
US20060127477A1
Human necessities

Preparation and administration form comprising an acid-labile active compound

#46 | 2006-05-18 βœ… Patent 7,947,744 granted on 2011-05-24
US20060104917A1
Human necessities

Stable pharmaceutical products

#47 | 2006-02-02 βœ… Patent 7,879,833 granted on 2011-02-01
US20060025392A1
Human necessities

Combination medicament

#48 | 2005-12-29 βœ… Patent 7,452,998 granted on 2008-11-18
US20050288334A1
Chemistry; metallurgy

Process for preparing optically pure active compounds

#49 | 2005-10-27 βœ… Patent 7,423,046 granted on 2008-09-09
US20050239818A1
Chemistry; metallurgy

3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors

#50 | 2005-10-27 βœ… Patent 7,329,676 granted on 2008-02-12
US20050239817A1
Chemistry; metallurgy

2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors

#51 | 2005-07-21 βœ… Patent 7,951,397 granted on 2011-05-31
US20050159492A1
Human necessities

Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient

#52 | 2005-04-14 βœ… Patent 7,468,433 granted on 2008-12-23
US20050080063A1
Chemistry; metallurgy

Process for the production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21-dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation

Also check out Nycomed GmbH's (Constance, Germany) applicant profile with 1 patent applications submitted.

AssigneeID:

399720 ⎘